Related Experiment Video
Updated: Sep 8, 2025
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.2K
Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?
Jason Yongsheng Chan1, Jing Quan Lim2, Choon Kiat Ong2
1Division of Medical Oncology, National Cancer Centre Singapore, 169610, Singapore.
Precision Clinical Medicine
|June 13, 2022
Summary
This commentary discusses combining anti-PD-1 antibodies with P-GEMOX chemotherapy for advanced natural killer/T cell lymphoma. This immunochemotherapy approach shows potential for improved treatment outcomes in this aggressive cancer.
Area of Science:
- Oncology
- Immunotherapy
- Hematology
Background:
- Advanced natural killer/T cell lymphoma (NKTL) has a poor prognosis.
- Current treatment options for advanced NKTL are limited.
- Immunochemotherapy represents a promising strategy for NKTL.
Purpose of the Study:
- To comment on the potential efficacy of combining anti-PD-1 antibodies with P-GEMOX chemotherapy.
- To explore the rationale behind this immunochemotherapy combination for advanced NKTL.
Main Methods:
- Review and commentary on existing literature and proposed treatment strategies.
- Discussion of the synergistic potential between immunotherapy and chemotherapy.
Main Results:
- The combination of anti-PD-1 antibody and P-GEMOX is hypothesized to enhance anti-tumor immune responses.
- This approach may overcome resistance mechanisms in advanced NKTL.
Conclusions:
- Combination anti-PD-1 antibody with P-GEMOX is a potentially effective immunochemotherapy for advanced NKTL.
- Further clinical investigation is warranted to validate this therapeutic strategy.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
01:27Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
01:28Cells of the Innate Immune Response
3.1K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.1K